0R34 · Johnson & Johnson
253.66
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$611.29B
PE
18.80
EV/EBITDA
15.8
DIV Yield
2.5%
Payout Ratio
47%
MQV Rating
5Very Weak
As at 15/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- Hammer Bearish
Key Fundamentals
EPS 3 yr Growth
62.90%
EBITDA Margin
35.70%
Operating Cashflow
$24,530m
Free Cash Flow Return
21.70%
ROIC
23.70%
Interest Coverage
22.60
Quick Ratio
0.80
Performance
52 weeks range
Low 184.47 - 281.2
Trade Value (12mth)
US$830,746.00
1 week
-0.8%
1 month
-5.72%
YTD
22.63%
1 year
33.01%
All time high
281.20
Additional Data
Shares Outstanding (Fully Diluted)
2,449m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
24-Nov-26
Next Dividend Pay Date
08-Dec-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Wellcome Trust Ltd. (Direct Investments) | Operating Division |
| Joaquin Duato | Individual |
| Employees Provident Fund (Investment Management) | Operating Division |
| Jennifer L. Taubert | Individual |
| Kathryn E. Wengel | Individual |
